Home

Dummkopf Dilemma Wiege antibody levels after third dose Unebenheit Impuls Fabrik

COVID-19 mRNA vaccines and fever: A possible | EurekAlert!
COVID-19 mRNA vaccines and fever: A possible | EurekAlert!

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general  population of the United Kingdom | Nature Microbiology
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom | Nature Microbiology

Antibody response to SARS-CoV-2 infection in humans: A systematic review |  PLOS ONE
Antibody response to SARS-CoV-2 infection in humans: A systematic review | PLOS ONE

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet

Early antibody response in health-care professionals after two doses of  SARS-CoV-2 mRNA vaccine (BNT162b2) - Clinical Microbiology and Infection
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2) - Clinical Microbiology and Infection

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA  vaccine - ScienceDirect
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect

Frontiers | The Mucosal and Serological Immune Responses to the Novel  Coronavirus (SARS-CoV-2) Vaccines
Frontiers | The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines

Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19  vaccination | medRxiv
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination | medRxiv

Boosting immunity to Omicron | Nature Medicine
Boosting immunity to Omicron | Nature Medicine

Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and  immunity after natural SARS-CoV-2 infection—A comparative study from Novi  Sad, Serbia | PLOS ONE
Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia | PLOS ONE

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and  recovered individuals after mRNA vaccination | Science Immunology
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology

Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19  Vaccines: Why, Who, When and What
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What

Testing fractional doses of COVID-19 vaccines | PNAS
Testing fractional doses of COVID-19 vaccines | PNAS

HKUMed-CU Medicine joint study finds that third dose of Comirnaty has  better protection from COVID-19 variant Omicron - Press Releases - Media -  HKU
HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron - Press Releases - Media - HKU

Antibody Responses in Seropositive Persons after a Single Dose of  SARS-CoV-2 mRNA Vaccine | NEJM
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM

Vaccines | Free Full-Text | Significant Increase in Antibody Titers after  the 3rd Booster Dose of the Pfizer–BioNTech mRNA COVID-19 Vaccine in  Healthcare Workers in Greece
Vaccines | Free Full-Text | Significant Increase in Antibody Titers after the 3rd Booster Dose of the Pfizer–BioNTech mRNA COVID-19 Vaccine in Healthcare Workers in Greece

Frontiers | A Third Dose of an Inactivated Vaccine Dramatically Increased  the Levels and Decay Times of Anti-SARS-CoV-2 Antibodies, but  Disappointingly Declined Again: A Prospective, Longitudinal, Cohort Study  at 18 Serial Time
Frontiers | A Third Dose of an Inactivated Vaccine Dramatically Increased the Levels and Decay Times of Anti-SARS-CoV-2 Antibodies, but Disappointingly Declined Again: A Prospective, Longitudinal, Cohort Study at 18 Serial Time

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant  Recipients | NEJM
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients | NEJM

Several studies suggest single dose of vaccine provides strong protection  for people who have recovered from COVID-19 - COVID-19 Immunity Task Force
Several studies suggest single dose of vaccine provides strong protection for people who have recovered from COVID-19 - COVID-19 Immunity Task Force

Vaccines | Free Full-Text | Quantitative Analysis of Anti-N and Anti-S Antibody  Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination
Vaccines | Free Full-Text | Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA  Covid-19 vaccination: a three-case series
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA  Covid-19 vaccination: a three-case series
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series

Comparison of IgG and neutralizing antibody responses after one or two doses  of COVID-19 mRNA vaccine in previously infected and uninfected individuals.  - eClinicalMedicine
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals. - eClinicalMedicine

Frontiers Publishing Partnerships | Immune Response to Third Dose BNT162b2  COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study
Frontiers Publishing Partnerships | Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study